Skip to main
BWAY

Brainsway (BWAY) Stock Forecast & Price Target

Brainsway (BWAY) Analyst Ratings

Based on 4 analyst ratings
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

BrainsWay is expected to see continued growth and success in the coming years due to their strong financial results and focus on expansion and new indications. The company's sustainable and profitable commercial model, strong balance sheet, and promising pipeline all contribute to a positive outlook for its stock. However, risks such as competition and execution issues should be closely monitored.

Bears say

BrainsWay is continuing to execute on their minority investment program, with their deep TMS appointment volume growing significantly from Q2 to Q4 of 2025 and their goal of expanding international revenue to 30-40% within five years. However, there are potential risks associated with inconsistent commercial execution and competition in the interventional psychiatry space, as well as the upcoming introduction of Compass Pathways' psilocybin therapy. These factors could impact BrainsWay's profitability and stock performance.

Brainsway (BWAY) has been analyzed by 4 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 25% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Brainsway and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Brainsway (BWAY) Forecast

Analysts have given Brainsway (BWAY) a Strong Buy based on their latest research and market trends.

According to 4 analysts, Brainsway (BWAY) has a Strong Buy consensus rating as of Sep 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $20.20, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $20.20, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Brainsway (BWAY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.